These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11091753)

  • 21. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
    Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
    Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.
    Rhiem K; Todt U; Wappenschmidt B; Klein A; Wardelmann E; Schmutzler RK
    Anticancer Res; 2010 Sep; 30(9):3445-9. PubMed ID: 20944121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of loss of heterozygosity of the tumor suppressor genes p53 and BRCA1 in ovarial carcinomas].
    Petrović B; Perović M; Novaković I; Atanacković J; Popović B; Luković L; Petković S
    Vojnosanit Pregl; 2006 Sep; 63(9):813-8. PubMed ID: 17039893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.
    Hanby AM; Kelsell DP; Potts HW; Gillett CE; Bishop DT; Spurr NK; Barnes DM
    Int J Cancer; 2000 Oct; 88(2):204-8. PubMed ID: 11004669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.
    Querzoli P; Albonico G; di Iasio MG; Ferretti S; Rinaldi R; Cariello A; Pedriali M; Matteuzzi M; Maestri I; Nenci I
    Breast Cancer Res Treat; 2001 Mar; 66(2):135-42. PubMed ID: 11437099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene.
    Rio PG; Maurizis JC; Peffault de Latour M; Bignon YJ; Bernard-Gallon DJ
    Int J Cancer; 1999 Mar; 80(6):823-6. PubMed ID: 10074913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
    Okada S; Tokunaga E; Kitao H; Akiyoshi S; Yamashita N; Saeki H; Oki E; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 May; 19(5):1499-507. PubMed ID: 22179631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
    Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
    Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
    Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer.
    Niederacher D; An HX; Camrath S; Dominik SI; Göhring UJ; Oertel A; Grass M; Hantschmann P; Lordnejad MR; Beckmann MW
    Eur J Cancer; 1998 Oct; 34(11):1770-6. PubMed ID: 9893667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability.
    Vaurs-Barriere C; Vidal V; Penault-Llorca F; Kwiatkowski F; Maugard C; Bignon Y
    Int J Oncol; 1998 Jun; 12(6):1373-8. PubMed ID: 9592202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.
    Wistuba II; Tomlinson GE; Behrens C; Virmani A; Geradts J; Blum JL; Minna JD; Gazdar AF
    Genes Chromosomes Cancer; 2000 Aug; 28(4):359-69. PubMed ID: 10862044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
    Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers.
    Dinesh KP; Devaraj H; Murugan V; Rajaraman R; Niranjali S
    Mol Cell Biochem; 2006 Jul; 287(1-2):177-83. PubMed ID: 16718381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.
    Kerangueven F; Eisinger F; Noguchi T; Allione F; Wargniez V; Eng C; Padberg G; Theillet C; Jacquemier J; Longy M; Sobol H; Birnbaum D
    Oncogene; 1997 Jan; 14(3):339-47. PubMed ID: 9018120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer.
    Garcia-Patiño E; Gomendio B; Lleonart M; Silva JM; Garcia JM; Provencio M; Cubedo R; España P; Ramón y Cajal S; Bonilla F
    Cancer Genet Cytogenet; 1998 Jul; 104(2):119-23. PubMed ID: 9666805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.